c24 ceramide Search Results


93
Santa Cruz Biotechnology egr3
Egr3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c24+ceramide/pmc02582946-282-18-26?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
egr3 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

95
Croda International Plc ceramide species
Ceramide Species, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c24+ceramide/pmc10450669-169-22-33?v=Croda+International+Plc
Average 95 stars, based on 1 article reviews
ceramide species - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

95
Croda International Plc 860524p

860524p, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c24+ceramide/pmc05501726-88-9-5?v=Croda+International+Plc
Average 95 stars, based on 1 article reviews
860524p - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

91
Toronto Research Chemicals c 24 ceramide
<t>Ceramide-CD300f</t> binding inhibited the release of chemical mediators from LPS-stimulated mast cells and neutrophils in vitro . A and B , the levels of MIP2 or LTC4 released from WT or CD300f −/− BMMC ( A ) or neutrophils ( B ) stimulated with 100 ng/ml LPS for 6 h. Cells were preincubated on plates coated with ceramide, PC, or vehicle for 1 h before stimulation. Data are representative of three independent experiments. Means ± S.D. are plotted. *, p < 0.01 (Student's t test).
C 24 Ceramide, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c24+ceramide/pmc05314187-89-7-12?v=Toronto+Research+Chemicals
Average 91 stars, based on 1 article reviews
c 24 ceramide - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

93
Croda International Plc c24
The differential abundance of plasma ceramide species. In plasma, the distribution of ceramides is relatively fluctuating, with <t>C24:0</t> being the most abundant and C18:0 the least concentration ( A ). Likewise, C24:1/C22:0 and C18:0/C24:0 are the highest and lowest ratios of plasma ceramide, respectively ( B ). Independent two-tailed t-test has shown a significant difference between males and females in all measured ceramide species, except for the concentration of C24:0 (ns; not significant P > 0.05) ( C ), and the ratio of C18:0/22:0 ( P > 0.05) ( D ). Data are presented as Mean ± SEM
C24, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c24+ceramide/pmc10983633-141-14-22?v=Croda+International+Plc
Average 93 stars, based on 1 article reviews
c24 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

91
Croda International Plc synthetic β glccer
The differential abundance of plasma ceramide species. In plasma, the distribution of ceramides is relatively fluctuating, with <t>C24:0</t> being the most abundant and C18:0 the least concentration ( A ). Likewise, C24:1/C22:0 and C18:0/C24:0 are the highest and lowest ratios of plasma ceramide, respectively ( B ). Independent two-tailed t-test has shown a significant difference between males and females in all measured ceramide species, except for the concentration of C24:0 (ns; not significant P > 0.05) ( C ), and the ratio of C18:0/22:0 ( P > 0.05) ( D ). Data are presented as Mean ± SEM
Synthetic β Glccer, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c24+ceramide/pm41331311-151-18-25?v=Croda+International+Plc
Average 91 stars, based on 1 article reviews
synthetic β glccer - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

93
Croda International Plc laccer
The differential abundance of plasma ceramide species. In plasma, the distribution of ceramides is relatively fluctuating, with <t>C24:0</t> being the most abundant and C18:0 the least concentration ( A ). Likewise, C24:1/C22:0 and C18:0/C24:0 are the highest and lowest ratios of plasma ceramide, respectively ( B ). Independent two-tailed t-test has shown a significant difference between males and females in all measured ceramide species, except for the concentration of C24:0 (ns; not significant P > 0.05) ( C ), and the ratio of C18:0/22:0 ( P > 0.05) ( D ). Data are presented as Mean ± SEM
Laccer, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c24+ceramide/pm41331311-163-13-17?v=Croda+International+Plc
Average 93 stars, based on 1 article reviews
laccer - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

94
Croda International Plc mono sulfo galactosyl ß ceramide d7
The differential abundance of plasma ceramide species. In plasma, the distribution of ceramides is relatively fluctuating, with <t>C24:0</t> being the most abundant and C18:0 the least concentration ( A ). Likewise, C24:1/C22:0 and C18:0/C24:0 are the highest and lowest ratios of plasma ceramide, respectively ( B ). Independent two-tailed t-test has shown a significant difference between males and females in all measured ceramide species, except for the concentration of C24:0 (ns; not significant P > 0.05) ( C ), and the ratio of C18:0/22:0 ( P > 0.05) ( D ). Data are presented as Mean ± SEM
Mono Sulfo Galactosyl ß Ceramide D7, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c24+ceramide/bio_rxiv__64898__2026__03__13__711741-107-27-31?v=Croda+International+Plc
Average 94 stars, based on 1 article reviews
mono sulfo galactosyl ß ceramide d7 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

90
Croda International Plc cerc24
Integrated chromatograms, stability, and specificity of the liquid chromatography-mass spectrometry (LC-MS/MS) ceramide quantification assay. During the 5-minute run, Mobile Phase A comprised 10 mM ammonium formate and 0.1% formic acid in LC-MS grade water. Mobile Phase B contained 10 mM ammonium formate and 0.1% formic acid in LC-MS grade water/acetonitrile/isopropanol (5%: 47.5%: 47.5%) (A) . Ceramide metabolites and internal standards were separated adequately based on molecular weights and polarities ( B - C ). The stability of ceramide metabolites over three freeze/thaw cycles showed percentage changes represented by blue, orange, and grey bars after 24, 48, and 72 h, respectively. Quality control levels confirmed percentage changes within ± 7% for all metabolites CerC16:0 ( D ), CerC18:0 ( E ), CerC22:0 ( F ), <t>CerC24:0</t> ( G ), and CerC24:1 ( H ). Overlaid chromatograms of blank samples ( I ) confirmed method specificity, showing no interfering peaks at the respective retention times for ceramide metabolites. IS, Internal Standard; %change, stability
Cerc24, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c24+ceramide/pmc10983633-142-16-23?v=Croda+International+Plc
Average 90 stars, based on 1 article reviews
cerc24 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Croda International Plc o sulfo d galactosyl bl
Integrated chromatograms, stability, and specificity of the liquid chromatography-mass spectrometry (LC-MS/MS) ceramide quantification assay. During the 5-minute run, Mobile Phase A comprised 10 mM ammonium formate and 0.1% formic acid in LC-MS grade water. Mobile Phase B contained 10 mM ammonium formate and 0.1% formic acid in LC-MS grade water/acetonitrile/isopropanol (5%: 47.5%: 47.5%) (A) . Ceramide metabolites and internal standards were separated adequately based on molecular weights and polarities ( B - C ). The stability of ceramide metabolites over three freeze/thaw cycles showed percentage changes represented by blue, orange, and grey bars after 24, 48, and 72 h, respectively. Quality control levels confirmed percentage changes within ± 7% for all metabolites CerC16:0 ( D ), CerC18:0 ( E ), CerC22:0 ( F ), <t>CerC24:0</t> ( G ), and CerC24:1 ( H ). Overlaid chromatograms of blank samples ( I ) confirmed method specificity, showing no interfering peaks at the respective retention times for ceramide metabolites. IS, Internal Standard; %change, stability
O Sulfo D Galactosyl Bl, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c24+ceramide/fincher_jarod_ashton__2019__direct_analysis_and_imaging_of_biological_tissues_by_laesi_and_napa_ldi_mass_spectrometry-331-24-38?v=Croda+International+Plc
Average 90 stars, based on 1 article reviews
o sulfo d galactosyl bl - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Journal: Cell Metabolism

Article Title: Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance

doi: 10.1016/j.cmet.2017.06.014

Figure Lengend Snippet:

Article Snippet: N-lignoceroyl-D-erythro-sphingosine. C24 Ceramide (d18:1/24:0) , Avanti Polar Lipids , 860524P.

Techniques: Virus, Recombinant, Electron Microscopy, Labeling, Protease Inhibitor, Enzyme-linked Immunosorbent Assay, In Situ Hybridization, Software, In Vivo Imaging, Imaging, Transmission Assay, Microscopy, Thin Layer Chromatography, Mass Spectrometry, Real-time Polymerase Chain Reaction, Membrane

Ceramide-CD300f binding inhibited the release of chemical mediators from LPS-stimulated mast cells and neutrophils in vitro . A and B , the levels of MIP2 or LTC4 released from WT or CD300f −/− BMMC ( A ) or neutrophils ( B ) stimulated with 100 ng/ml LPS for 6 h. Cells were preincubated on plates coated with ceramide, PC, or vehicle for 1 h before stimulation. Data are representative of three independent experiments. Means ± S.D. are plotted. *, p < 0.01 (Student's t test).

Journal: The Journal of Biological Chemistry

Article Title: Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation *

doi: 10.1074/jbc.M116.768366

Figure Lengend Snippet: Ceramide-CD300f binding inhibited the release of chemical mediators from LPS-stimulated mast cells and neutrophils in vitro . A and B , the levels of MIP2 or LTC4 released from WT or CD300f −/− BMMC ( A ) or neutrophils ( B ) stimulated with 100 ng/ml LPS for 6 h. Cells were preincubated on plates coated with ceramide, PC, or vehicle for 1 h before stimulation. Data are representative of three independent experiments. Means ± S.D. are plotted. *, p < 0.01 (Student's t test).

Article Snippet: Cytokines were obtained from R&D Systems, and C-24 ceramide was obtained from Toronto Research Chemicals, Inc. 1,2-Dipalmitoyl- sn -glycero-3-phosphocholine (PC) was obtained from Echelon Biosciences Inc.

Techniques: Binding Assay, In Vitro

Ceramide-CD300f binding inhibits LPS-induced skin inflammation. A and B , dye extravasation in ears of WT and CD300f −/− mice 1 h after intradermal injection with LPS. OD , optical density. C and D , the number of neutrophils recruited to skin pouches of WT and CD300f −/− mice 4 h after intradermal injection with LPS. A–D , ,ice intradermally injected with CD300f-Fc or control Fc ( A ), ceramide antibody or control antibody ( B and C ), or vesicles containing ceramide, PC, or vehicle ( D ) 1 h before LPS injection. Data are representative of two independent experiments. Means ± S.D. are plotted. *, p < 0.01 (Student's t test).

Journal: The Journal of Biological Chemistry

Article Title: Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation *

doi: 10.1074/jbc.M116.768366

Figure Lengend Snippet: Ceramide-CD300f binding inhibits LPS-induced skin inflammation. A and B , dye extravasation in ears of WT and CD300f −/− mice 1 h after intradermal injection with LPS. OD , optical density. C and D , the number of neutrophils recruited to skin pouches of WT and CD300f −/− mice 4 h after intradermal injection with LPS. A–D , ,ice intradermally injected with CD300f-Fc or control Fc ( A ), ceramide antibody or control antibody ( B and C ), or vesicles containing ceramide, PC, or vehicle ( D ) 1 h before LPS injection. Data are representative of two independent experiments. Means ± S.D. are plotted. *, p < 0.01 (Student's t test).

Article Snippet: Cytokines were obtained from R&D Systems, and C-24 ceramide was obtained from Toronto Research Chemicals, Inc. 1,2-Dipalmitoyl- sn -glycero-3-phosphocholine (PC) was obtained from Echelon Biosciences Inc.

Techniques: Binding Assay, Injection, Control

The differential abundance of plasma ceramide species. In plasma, the distribution of ceramides is relatively fluctuating, with C24:0 being the most abundant and C18:0 the least concentration ( A ). Likewise, C24:1/C22:0 and C18:0/C24:0 are the highest and lowest ratios of plasma ceramide, respectively ( B ). Independent two-tailed t-test has shown a significant difference between males and females in all measured ceramide species, except for the concentration of C24:0 (ns; not significant P > 0.05) ( C ), and the ratio of C18:0/22:0 ( P > 0.05) ( D ). Data are presented as Mean ± SEM

Journal: Lipids in Health and Disease

Article Title: Circulating ceramide levels and ratios in Emirati youth under 18 years: associations with cardiometabolic risk factors

doi: 10.1186/s12944-024-02080-6

Figure Lengend Snippet: The differential abundance of plasma ceramide species. In plasma, the distribution of ceramides is relatively fluctuating, with C24:0 being the most abundant and C18:0 the least concentration ( A ). Likewise, C24:1/C22:0 and C18:0/C24:0 are the highest and lowest ratios of plasma ceramide, respectively ( B ). Independent two-tailed t-test has shown a significant difference between males and females in all measured ceramide species, except for the concentration of C24:0 (ns; not significant P > 0.05) ( C ), and the ratio of C18:0/22:0 ( P > 0.05) ( D ). Data are presented as Mean ± SEM

Article Snippet: The powder forms of CerC16:0 [C16:0-ceramide (d18:1/16:0)], CerC18:0 [C18:0-ceramide (d18:1/18:0)], CerC22:0 [C22:0-ceramide (d18:1/22:0)], CerC24:0 [C24:0-ceramide (d18:1/24:0)], CerC24:1 [C24:1-ceramide (d18:1/24:1(15Z))] were purchased from Avanti Polar Lipids [Alabaster, AL].

Techniques: Clinical Proteomics, Concentration Assay, Two Tailed Test

Integrated chromatograms, stability, and specificity of the liquid chromatography-mass spectrometry (LC-MS/MS) ceramide quantification assay. During the 5-minute run, Mobile Phase A comprised 10 mM ammonium formate and 0.1% formic acid in LC-MS grade water. Mobile Phase B contained 10 mM ammonium formate and 0.1% formic acid in LC-MS grade water/acetonitrile/isopropanol (5%: 47.5%: 47.5%) (A) . Ceramide metabolites and internal standards were separated adequately based on molecular weights and polarities ( B - C ). The stability of ceramide metabolites over three freeze/thaw cycles showed percentage changes represented by blue, orange, and grey bars after 24, 48, and 72 h, respectively. Quality control levels confirmed percentage changes within ± 7% for all metabolites CerC16:0 ( D ), CerC18:0 ( E ), CerC22:0 ( F ), CerC24:0 ( G ), and CerC24:1 ( H ). Overlaid chromatograms of blank samples ( I ) confirmed method specificity, showing no interfering peaks at the respective retention times for ceramide metabolites. IS, Internal Standard; %change, stability

Journal: Lipids in Health and Disease

Article Title: Circulating ceramide levels and ratios in Emirati youth under 18 years: associations with cardiometabolic risk factors

doi: 10.1186/s12944-024-02080-6

Figure Lengend Snippet: Integrated chromatograms, stability, and specificity of the liquid chromatography-mass spectrometry (LC-MS/MS) ceramide quantification assay. During the 5-minute run, Mobile Phase A comprised 10 mM ammonium formate and 0.1% formic acid in LC-MS grade water. Mobile Phase B contained 10 mM ammonium formate and 0.1% formic acid in LC-MS grade water/acetonitrile/isopropanol (5%: 47.5%: 47.5%) (A) . Ceramide metabolites and internal standards were separated adequately based on molecular weights and polarities ( B - C ). The stability of ceramide metabolites over three freeze/thaw cycles showed percentage changes represented by blue, orange, and grey bars after 24, 48, and 72 h, respectively. Quality control levels confirmed percentage changes within ± 7% for all metabolites CerC16:0 ( D ), CerC18:0 ( E ), CerC22:0 ( F ), CerC24:0 ( G ), and CerC24:1 ( H ). Overlaid chromatograms of blank samples ( I ) confirmed method specificity, showing no interfering peaks at the respective retention times for ceramide metabolites. IS, Internal Standard; %change, stability

Article Snippet: The powder forms of Cer internal standards CerC16:0-d7 [C16:0-ceramide-d7 (d18:1-d7/16:0)], CerC18:0-d7 [C18:0-ceramide-d7 (d18:1-d7/18:0)], CerC24:0-d7 [C24:0-ceramide-d7 (d18:1-d7/24:0)], CerC24:1-d7 [C24:1-ceramide-d7 (d18:1-d7/24:1(15Z))] were also purchased from Avanti Polar Lipids [Alabaster, AL].

Techniques: Liquid Chromatography, Mass Spectrometry, Liquid Chromatography with Mass Spectroscopy, Control

The Multiple Reaction Monitoring (MRM) parameters of ceramide metabolites and corresponding internal standards

Journal: Lipids in Health and Disease

Article Title: Circulating ceramide levels and ratios in Emirati youth under 18 years: associations with cardiometabolic risk factors

doi: 10.1186/s12944-024-02080-6

Figure Lengend Snippet: The Multiple Reaction Monitoring (MRM) parameters of ceramide metabolites and corresponding internal standards

Article Snippet: The powder forms of Cer internal standards CerC16:0-d7 [C16:0-ceramide-d7 (d18:1-d7/16:0)], CerC18:0-d7 [C18:0-ceramide-d7 (d18:1-d7/18:0)], CerC24:0-d7 [C24:0-ceramide-d7 (d18:1-d7/24:0)], CerC24:1-d7 [C24:1-ceramide-d7 (d18:1-d7/24:1(15Z))] were also purchased from Avanti Polar Lipids [Alabaster, AL].

Techniques: Targeted Proteomics

The liquid chromatography-mass spectrometry (LC-MS/MS) ceramide quantification assay validation results

Journal: Lipids in Health and Disease

Article Title: Circulating ceramide levels and ratios in Emirati youth under 18 years: associations with cardiometabolic risk factors

doi: 10.1186/s12944-024-02080-6

Figure Lengend Snippet: The liquid chromatography-mass spectrometry (LC-MS/MS) ceramide quantification assay validation results

Article Snippet: The powder forms of Cer internal standards CerC16:0-d7 [C16:0-ceramide-d7 (d18:1-d7/16:0)], CerC18:0-d7 [C18:0-ceramide-d7 (d18:1-d7/18:0)], CerC24:0-d7 [C24:0-ceramide-d7 (d18:1-d7/24:0)], CerC24:1-d7 [C24:1-ceramide-d7 (d18:1-d7/24:1(15Z))] were also purchased from Avanti Polar Lipids [Alabaster, AL].

Techniques: Chromatography, Biomarker Discovery, Concentration Assay

Comparative results of the liquid chromatography-mass spectrometry (LC-MS/MS) ceramide quantification assay in this study and other relevant studies

Journal: Lipids in Health and Disease

Article Title: Circulating ceramide levels and ratios in Emirati youth under 18 years: associations with cardiometabolic risk factors

doi: 10.1186/s12944-024-02080-6

Figure Lengend Snippet: Comparative results of the liquid chromatography-mass spectrometry (LC-MS/MS) ceramide quantification assay in this study and other relevant studies

Article Snippet: The powder forms of Cer internal standards CerC16:0-d7 [C16:0-ceramide-d7 (d18:1-d7/16:0)], CerC18:0-d7 [C18:0-ceramide-d7 (d18:1-d7/18:0)], CerC24:0-d7 [C24:0-ceramide-d7 (d18:1-d7/24:0)], CerC24:1-d7 [C24:1-ceramide-d7 (d18:1-d7/24:1(15Z))] were also purchased from Avanti Polar Lipids [Alabaster, AL].

Techniques: Chromatography, Extraction, Solvent, Injection, Modification

Median and 95% reference ranges of plasma ceramide levels and ratios in individuals aged 6–17 years

Journal: Lipids in Health and Disease

Article Title: Circulating ceramide levels and ratios in Emirati youth under 18 years: associations with cardiometabolic risk factors

doi: 10.1186/s12944-024-02080-6

Figure Lengend Snippet: Median and 95% reference ranges of plasma ceramide levels and ratios in individuals aged 6–17 years

Article Snippet: The powder forms of Cer internal standards CerC16:0-d7 [C16:0-ceramide-d7 (d18:1-d7/16:0)], CerC18:0-d7 [C18:0-ceramide-d7 (d18:1-d7/18:0)], CerC24:0-d7 [C24:0-ceramide-d7 (d18:1-d7/24:0)], CerC24:1-d7 [C24:1-ceramide-d7 (d18:1-d7/24:1(15Z))] were also purchased from Avanti Polar Lipids [Alabaster, AL].

Techniques: Clinical Proteomics